Q98441184

Summary

Q98441184 is an interpellation^[1].

Key Facts

• Q98441184 authored Thomas Nihlén^[2].
• Q98441184's instance of is recorded as interpellation^[3].
• Q98441184's part of the series is recorded as interpellations of the 2008/09 legislative session of the Riksdag^[4].
• Q98441184's language of work or name is recorded as Swedish^[5].
• Q98441184's publication date is recorded as +2008-11-11T00:00:00Z^[6].
• Q98441184's significant event is recorded as debate^[7].
• Q98441184's main subject is recorded as medication^[8].
• Q98441184's work available at URL is recorded as http://data.riksdagen.se/dokument/GW10108^[9].
• Q98441184's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GW10108^[10].
• Q98441184's applies to jurisdiction is recorded as Sweden^[11].
• Q98441184's legal citation of this text is recorded as ip. 2008/09:108^[12].
• Q98441184's title is recorded as Felaktig läkemedelsanvändning^[13].
• Q98441184's addressee is recorded as Göran Hägglund^[14].
• Q98441184's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98441184's copyright status is recorded as public domain^[16].
• Q98441184's Swedish Riksdag document ID is recorded as GW10108^[17].

Body

Works and Contributions

Q98441184 authored Thomas Nihlén^[2].